DFDA

Focal Therapies (Laser Photocoagulation, Transpupillary Thermotherapy, Cryotherapy)

Treatment for Retinoblastoma

Typical Dosage: Not applicable

Effectiveness
90%
Safety Score
75%
Clinical Trials
0
Participants
0

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
Not applicable
Time to Effect
immediate (full regression 2-4 weeks)
Treatment Duration
1-3 sessions
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$12,000
Side Effect Mgmt:$300
Total Annual:$12,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
20
Outcome-Based Costs
Cost per Responder
$14,205
Cost per Remission
$14,205
Comparison vs Systemic Chemotherapy
Cost Difference
$-62,500/year
Less expensive
QALY Difference
+0.75 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Focal Therapies (Laser Photocoagulation, Transpupillary Thermotherapy, Cryotherapy) Outcomes

for Retinoblastoma

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+88%
Remission Rate
+88%
Common Side Effects
Local tissue damage (scarring)
+15%
Temporary vision changes
+10%
Retinal detachment
+1%
Vitreous hemorrhage
+1%

Sources:

nih.gov
pediatricretinoblastoma.com
cancer.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov